AI analysis
200+drug approval records
Structure the records
An AI language model extracted drugs, indications and test models from US and EU approvals.
Case Study · Regulatory Intelligence
Tracking a shift in rodent model use.
A global leader in genetically engineered rodent models wanted to know how 2022 guideline changes affected carcinogenicity testing. We analyzed drug approval records with AI and consulted experts to show how transgenic model use changed.
The Client
The client is a global leader in genetically engineered rodent models and services. It wanted to see how new guidance changed model selection for small molecule drug testing.
The Challenge
New guidance.
What really changed?
Prescouter was asked to assess how 2022 carcinogenicity guideline changes affected testing of small molecule drugs and the choice of rodent models, especially transgenic mouse models.
-
Rules
Guideline change
International guidance updated in 2022.
-
Models
Model selection
Which rodent models were chosen.
-
Market
Indication trends
Disease areas favoring transgenics.
Our Approach
Pairing AI-driven record analysis with expert insight.
Before and after
2022guideline update analyzed
Compare the eras
We compared carcinogenicity testing before and after the guideline change to spot shifts.
Expert interviews
4experts interviewed
Add the context
Regulatory consultants and pharma toxicologists put the record analysis in context.
The Outcome
Clear signals for a marketing strategy.
Prescouter presented the changes observed after the guideline update, especially in transgenic rodent use. It identified opportunities by indication, since some disease areas were more likely to use transgenic models, and its expert insights helped the client shape a marketing strategy.
-
Shifts
Post-2022 changes
Transgenic rodent use tracked.
-
Targets
Indication opportunities
Disease areas most likely to adopt.
-
Strategy
Marketing plan input
Shaped by expert consultations.
Regulatory changes ripple slowly through drug approvals. Structured data shows the real shift before the market fully notices.
Let’s Talk
How will new rules reshape your market?
Turn regulatory records into a clear view of demand. Wherever you’re starting from, we’ll help you get there.
Or email [email protected]